Page 25 - Astrazeneca

AstraZeneca Covid-19 vaccine study paused after one 'unexplained' illness

Late-stage studies of AstraZeneca's Covid-19 vaccine candidate are on temporary hold while the company investigates whether a recipient's "potentially unexplained" illness is a side effect of the shot

New launches in key categories to trigger AstraZeneca Pharma's growth

Higher share of patented products, scope for margin improvement and chronic portfolio are key positives

AstraZeneca Pharma hits fresh record high of Rs 4,489; stock surges 15%

The stock of the company was trading higher for the fifth straight day, surging 26 per cent during the period.

Astrazeneca to begin Phase 1/2 clinical trials of Covid vaccine in Japan

Astrazeneca said on Friday it is beginning Phase 1/2 clinical trials in Japan of its coronavirus vaccine candidate

AstraZeneca Pharma India hits fresh record high, up 15% in 8 trading days

AstraZeneca Plc, the company's parent firm, is expected to release initial data on whether a vaccine can stop people from getting the virus on September 15

AstraZeneca begins coronavirus vaccine phase 3 clinical trials in US

The phase 3 trial is being implemented as part of Operation Warp Speed, a multi-agency collaboration led by the US Health and Human Services

AstraZeneca's Covid-19 vaccine candidate begins late-stage US study

The trial is being conducted under U.S. government's Operation Warp Speed program, which aims to accelerate development, manufacturing and distribution of vaccines and treatments for Covid-19

When will India finally have access to coronavirus vaccine?

India commands 40 per cent of global capacity for vaccines which is estimated at 5.7 billion doses

Covid updates: Job loss in India, Australia's 'vaccine must' policy, & more

Maharashtra has more than 600,000 confirmed coronavirus cases, which is almost equivalent to the case tally of the next two worst-affected states - Tamil Nadu and Andhra Pradesh - put together

Australia to give free Covid vaccine doses to citizens: PM Scott Morrison

Prime Minister Scott Morrison said Australia had reached a deal with Swedish-British pharmaceutical company AstraZeneca to receive the Covid-19 vaccine it is developing with Oxford University

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

Expects to complete trials by year-end

Blow to WHO? EU clinches first Covid-19 vaccine deal with AstraZeneca

The EU move could complicate efforts led by the WHO and GAVI, a global alliance for vaccines, to buy shots on behalf of rich and developing countries with a separate scheme

European Union, AstraZeneca agree bloc's first Covid-19 vaccine deal

The European Commission said on Friday it had reached a deal with British pharmaceutical firm AstraZeneca for the purchase of at least 300 million doses of its potential COVID-19 vaccine.

AstraZeneca says could begin Covid-19 vaccine production early in 2021

AstraZeneca Mexico's head said that Phase III trials were expected to conclude by November or December

US inks $1.5 bn deal with Moderna for 100 mn doses of Covid-19 'vaccine'

The US government previously gave Moderna around $1 billion to fund its research efforts, bringing total US funding to around $2.5 billion

AstraZeneca Pharma India Q1 net profit declines 13 pc at Rs 18.63 cr

Drug firm AstraZeneca Pharma India on Monday reported a 13.38 per centdecline in its net profit to Rs 18.63 crore for the quarter ended June. The company had posted a net profit of Rs 21.51 crore for the corresponding period of the previous fiscal, AstraZeneca Pharma India said in a BSE filing. Revenue from operations stood at Rs 193.57 crore for the quarter under consideration. It was Rs 204.56 crore for the same periodyear ago, it added. The board of directors has declared an interim dividend of Rs 2 per equity share for the financial year 2020-21, the filing said. Shares ofAstraZeneca Pharma India were trading at Rs3,381.65per scrip on BSE, up 1.50 per cent over previous close.

AstraZeneca in deal with Kangtai Bio to supply Covid-19 vaccine in China

AstraZeneca signed an exclusive framework agreement with China's Shenzhen Kangtai Biological Products to supply its Covid-19 vaccine candidate in mainland China

Rich nations rush to lock up Covid vaccines: What about rest of the world?

Moves by the US and UK to secure supplies from Sanofi and partner GlaxoSmithKline Plc, and another pact between Japan and Pfizer Inc., are the latest in a string of agreements

AstraZeneca betters estimates amid strong sales, Covid-19 vaccine hopes

The company reiterated that it was on track with late-stage trials for its coronavirus vaccine, which could be rolled out by the year-end

AstraZeneca's drug gets US FDA nod to treat lung disease patients

The drug Breztri Aerosphere is being approved as a maintenance treatment for patients with chronic obstructive pulmonary disease (COPD), the third leading cause of death globally